CytRx Corporation (CYTR)

OTCMKTS: CYTR · Delayed Price · USD
+0.0067 (7.19%)
Jul 1, 2022 4:00 PM - Market closed

Total Valuation

CytRx has a market cap or net worth of $4.50 million. The enterprise value is -$1.86 million.

Market Cap 4.50M
Enterprise Value -1.86M

Important Dates

The latest earnings date was Wednesday, May 11, 2022, before market open.

Last Earnings Date May 11, 2022
Ex-Dividend Date n/a

Share Statistics

CytRx has 45.04 million shares outstanding. The number of shares has increased by 7.52% in one year.

Shares Outstanding 45.04M
Shares Change (YoY) +7.52%
Shares Change (QoQ) +1.71%
Owned by Insiders (%) 14.14%
Owned by Institutions (%) 9.44%
Float 34.10M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 5.97
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.55.

Current Ratio 2.22
Quick Ratio 1.87
Debt / Equity 0.55
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -215.40%, which is considered low.

Return on Equity (ROE) -215.40%
Return on Assets (ROA) -116.90%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$4.39B
Employee Count 3
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -89.48% in the last 52 weeks. The beta is 2.19, so CytRx's price volatility has been higher than the market average.

Beta (1Y) 2.19
52-Week Price Change -89.48%
50-Day Moving Average 0.12
200-Day Moving Average 0.32
Average Volume (30 Days) 195,691

Short Selling Information

The latest short interest is 294,308, so 0.65% of the outstanding shares have been sold short.

Short Interest 294,308
Short % of Shares Out 0.65%
Short % of Float 0.86%
Short Ratio (days to cover) 1.96

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -5.98M
Net Income -13.18M
Net Income Common -13.18B
EBITDA -13.16M
EBIT -13.18M
Earnings Per Share (EPS) -$0.36
Full Income Statement

Balance Sheet

The company has $6.77 million in cash and $415,200 in debt, giving a net cash position of $6.35 million or $0.14 per share.

Cash & Cash Equivalents 6.77M
Total Debt 415,200
Net Cash 6.35M
Net Cash Per Share $0.14
Book Value 753,719
Book Value Per Share 0.02
Working Capital 4.55M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.31 million and capital expenditures -$7,004, giving a free cash flow of -$12.32 million.

Operating Cash Flow -12.31M
Capital Expenditures -7,004
Free Cash Flow -12.32M
FCF Per Share n/a
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CytRx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -292,864.89%
FCF Yield -273.73%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -8.47%
Shareholder Yield -8.47%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Buy
Analyst Count 7
Stock Forecasts

Stock Splits

The last stock split was on November 1, 2017. It was a reverse split with a ratio of 1:6.

Last Split Date Nov 1, 2017
Split Type Reverse
Split Ratio 1:6